Carbonyl formation on a copper-bound prion protein fragment, PrP23–98, associated with its dopamine oxidase activity  by Shiraishi, Noriyuki & Nishikimi, Morimitsu
Carbonyl formation on a copper-bound prion protein fragment, PrP23ÿ98,
associated with its dopamine oxidase activity
Noriyuki Shiraishi, Morimitsu Nishikimi*
Department of Biochemistry, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan
Received 17 November 2001; revised 18 December 2001; accepted 18 December 2001
First published online 7 January 2002
Edited by Barry Halliwell
Abstract The amino-terminal part of prion protein (PrP),
containing a series of octapeptide repeats with the consensus
sequence PHGGGWGQ, has been implicated in the binding of
copper ion. This region possesses amino acid residues susceptible
to oxidation, such as histidine, lysine, arginine and proline. In
this study, we have investigated copper-catalyzed oxidation of an
N-terminal part of human PrP, PrP23ÿ98, that was prepared by
the recombinant DNA technique. Carbonyl formations on
copper-bound PrP23ÿ98 induced by dopamine and L-ascorbate
were analyzed kinetically, and it was found that the redox cycling
of PrP23ÿ98-bound copper, especially induced by dopamine, was
coupled to the formation of carbonyls on the protein. ß 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Multiple lines of evidence have suggested that the most
important mechanism of oxidative damage to proteins in-
volves catalysis by transition metals bound to them. This pro-
cess consists of reduction of Fe3 or Cu2 by electron donors,
such as O32 , catecholamines, L-ascorbate and mercaptanes,
and generation of OH radical through reduction of H2O2
by the reduced metals. This highly reactive free radical attacks
neighboring amino acid residues, producing carbonyl-contain-
ing derivatives. In addition, carbonyls are introduced to pro-
tein as a consequence of oxidative cleavage of the peptide
backbone. The carbonyls thus produced serve as an important
marker of oxidative protein damage. The carbonyl formation
is known to cause structural alterations and loss of biological
functions of proteins (for reviews, see [1^3]).
Previous work has established that the proline- and histi-
dine-rich octapeptide repeat region of the prion protein (PrP)
constitutes a copper-binding site [4^10]. Under physiological
conditions, this region binds four copper ions and is suspected
to be a target of copper-catalyzed oxidation. We studied the
pathophysiological aspect of the copper^PrP complex by us-
ing a fusion of glutathione S-transferase with an N-terminal
76-amino acid region of human PrP, designated PrP23ÿ98.
Carbonyl formation on the protein induced by Cu2 plus L-
ascorbate was marginal at a copper/protein molar ratio of 1,
but became obviously detectable at a molar ratio of 4 [11], in
accordance with the previous result obtained with a synthetic
peptide of the octapeptide repeat [9]. We also observed that an
appreciable amount of carbonyl was produced on PrP23ÿ98
fusion protein puri¢ed from Escherichia coli that had been
treated with a high concentration of copper [11]. More re-
cently, Requena et al. [12] have investigated metal-catalyzed
oxidation of the Syrian hamster recombinant SHa(29^231)
PrP in vitro and shown that incubation of this protein with
Cu2 and L-ascorbate causes a marked decrease in histidine
content concomitantly with an extensive structural transition
leading to aggregation.
Autoxidizable substances, such as L-ascorbate, dopamine,
3,4-dihydroxyphenylalanine, and noradrenaline, react with
O2 to generate O32 and H2O2 through catalysis by metal ion
[13,14]. Dopamine is present in various anatomical regions of
the brain, its extraordinarily high concentrations being found
in the striatum (37 and 53 WM in the caudate nucleus and
putamen of human, respectively) [15]. The L-ascorbate con-
centration in the cerebrospinal £uid is 150 WM [14], and the
L-ascorbate concentration in the brain is in millimolar levels
[16]. With these backgrounds in mind, we have investigated
copper-catalyzed oxidation of PrP23ÿ98. Studies on the e¡ect
of the interaction of copper and PrP have been done in two
ways. One is to use a mere mixture of the two, and the other
is to use copper-containing PrP previously prepared from re-
combinant PrP. Choosing the latter way, we have here studied
carbonyl formation on copper-bound PrP23ÿ98 induced by do-
pamine in comparison with that induced by L-ascorbate, and
found that the redox cycling of PrP23ÿ98-bound copper, espe-
cially induced by dopamine, was associated with formation of
carbonyls on the protein.
2. Materials and methods
2.1. Preparation of copper-loaded PrP
A fusion protein of glutathione S-transferase with the human
PrP23ÿ98 was expressed in E. coli [9]. Triton X-100 and sarcosyl
were added to a cell suspension in phosphate-bu¡ered saline (pH
7.4) to a ¢nal concentration of 2% and 4%, respectively [17]. The
suspension was sonicated three times for 10 s with a microtip soni-
cator. The crude lysate was applied to a glutathione-Sepharose 4B
column (Amersham Pharmacia Biotech UK Ltd., Buckinghamshire,
UK) that had been equilibrated with phosphate-bu¡ered saline (pH
7.4) containing 2% Triton X-100 and 4% sarcosyl. The column was
washed with the same bu¡er, and then with factor Xa cleavage bu¡er
(100 mM NaCl, 2 mM CaCl2 and 20 mM Tris^HCl, pH 8.0). Re-
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combinant PrP23ÿ98 was obtained by cleavage with factor Xa followed
by dialysis against 50 mM Mes bu¡er (pH 7.5) at 4‡C, and stored at
380‡C until use. The concentration of PrP23ÿ98 was determined spec-
trophotometrically by using a molar extinction coe⁄cient at 280 nm
of 36 334 M31 cm31, which was deduced from the contents of tryp-
tophan and tyrosine (molar extinction coe⁄cient 5609 M31 cm31 for
tryptophan and 1340 M31 cm31 for tyrosine). For preparation of
copper-loaded PrP23ÿ98, mixtures (2 ml) containing 50 mM Mes bu¡er
(pH 7.5), 15 WM PrP23ÿ98, and varying concentrations (10^110 WM) of
glycine^copper were incubated at 37‡C for 10 min and dialyzed at 4‡C
overnight against three changes of 2 l of 50 mM Mes bu¡er (pH 7.5).
The copper content of the resulting copper-loaded PrP23ÿ98 was mea-
sured by the £ameless mode with a Shimadzu atomic absorption spec-
trophotometer AA-6800 (Shimadzu, Kyoto, Japan).
2.2. Western blotting
Mixtures (1 ml) containing 50 mM Mes bu¡er (pH 7.5), 2 WM
copper-loaded PrP23ÿ98, and 100 WM L-ascorbate or 100 WM dopa-
mine were incubated at 37‡C for 30 min, then 100 Wl of 5 mM dieth-
ylenetriamine-N,N,NP,NPP,NPP-pentaacetic acid (DTPA) was added to
stop the reaction. After lyophilization, the samples were dissolved in
distilled water, and carbonyl contents were determined by SDS^poly-
acrylamide gel electrophoresis followed by Western blot analysis as
described [18]. The membranes were scanned on a scanner (EPSON
GT-9500), and relative intensities of the stained bands were deter-
mined using ATTO Densitograph Software Library, Version 4.0
(ATTO Co. Ltd., Tokyo, Japan).
2.3. Amino acid analysis
Control and oxidized copper-loaded PrP23ÿ98 were hydrolyzed in
6 M HCl/1% phenol at 150‡C for 1 h. The hydrolysates were dried
in a vacuum centrifuge and dissolved in deionized water. Amino acid
analysis was performed with a Hitachi L-8500 amino acid analyzer
(Hitachi Ltd., Tokyo, Japan).
2.4. Metal analysis
The above reaction mixtures used for Western blotting were also
used for the measurement of copper released from the protein upon
incubation. Aliquots of the reaction mixtures (400 Wl) were dispensed
into cups of Ultrafree-MC centrifugal ¢lter units (Biomax-5, Millipore
Corp., MA, USA) and centrifuged at 6700Ug at 10‡C for 3 min, and
the copper concentration of the resulting ¢ltrates was measured by
atomic absorption spectrophotometry.
2.5. Oxidation of reducing substances
Oxidation of L-ascorbate was traced spectrophotometrically by the
decrease in absorbance at 265 nm [19] at 37‡C with a Shimadzu UV-
visible recording spectrophotometer UV-2500 (Shimadzu, Kyoto, Ja-
pan), and oxidation of dopamine was followed spectrophotometrically
by the increase in absorbance at 490 nm (dopachrome formation) [20].
3. Results
Our present study aimed to examine the redox activity of
copper that was bound to human PrP23ÿ98. Since a prelimi-
nary ultra¢ltration experiment indicated that a substantial
amount of copper was ¢lterable from a mixture of the protein
and an equimolar amount of copper^glycine, we prepared
copper-loaded PrP23ÿ98 containing varying amounts of cop-
per, by incubation of mixtures of PrP23ÿ98 and copper^glycine
at 37‡C for 10 min followed by extensive dialysis and used for
the test of carbonyl formation by incubation with dopamine
and L-ascorbate. The copper-loaded PrP23ÿ98 was found to
produce carbonyls by incubation with dopamine or L-ascor-
bate, whereas in the absence of the reducing substances, no
signi¢cant increase in carbonyl was observed with all the
PrP23ÿ98 containing di¡erent amounts of copper (Fig. 1). It
is noted that in the incubation with dopamine, the largest
amount of carbonyl was detected on PrP23ÿ98 containing
0.44 mol of copper per mol of protein. The carbonyl forma-
tion tended to decrease with an increase in the copper content
of the protein. On the other hand, in the incubation with L-
ascorbate, only a marginal amount of carbonyl was detected
on PrP23ÿ98 containing 0.44 mol of copper per mol of protein;
the amount of carbonyl increased with an increase in the
bound copper. Table 1 summarizes the result of amino acid
analysis of copper-loaded PrP23ÿ98 oxidized by incubation
with dopamine. A decrease in histidine content (17^37%)
was observed dependently on the copper content of the
protein. While the losses of other amino acid residues were
not evident. Thus it is clear that histidine residues are
most susceptible to protein oxidation as is the case with the
Syrian hamster recombinant SHa(29^231) PrP oxidized by
copper ion plus L-ascorbate [12]. SDS^polyacrylamide gel
electrophoresis under non-reducing conditions showed no ob-
vious formation of polymeric forms of the protein, although
the incubation with L-ascorbate gave faint dimer bands
for PrP23ÿ98 samples with high copper contents (data not
shown).
To ascertain the participation of copper in the formation of
carbonyls on copper-loaded PrP23ÿ98, the inhibitory e¡ect of
copper chelators was tested (Fig. 2). The inhibition was com-
Fig. 1. Western blot immunoassay for carbonyls formed on copper-
loaded PrP23ÿ98. A: Western blot analysis for protein-bound car-
bonyls. Puri¢ed PrP23ÿ98 and copper-loaded PrP23ÿ98 containing
varying contents of copper were incubated at 2 WM for 30 min at
37‡C, in the absence (lane 1 and open bars) and presence of 100
WM dopamine (lanes 2^7 and hatched bars) or 100 WM L-ascorbate
(lanes 2^7 and closed bars). Western blot analysis was carried out
essentially as described [18]. The copper contents (in mol of copper/
mol of protein) of the PrP23ÿ98 samples were: lanes 1 and 2, 0.02;
lane 3, 0.44; lane 4, 0.89; lane 5, 1.04; lane 6, 2.10; and lane 7,
2.52. B: Quanti¢cation of the Western blot data. Signals of speci¢c
bands were quanti¢ed by densitometry and plotted as a percentage
of the control (PrP23ÿ98 incubated without reducing substances).
Data were means þ S.D. (n = 3).
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plete with the Cu1-speci¢c chelator bathocuproinedisulfonic
acid (BCS), indicating that copper was removed from the
PrP23ÿ98 and formed Cu1^BCS complex, rendering the cop-
per not readily oxidizable by O2. Although DTPA and EDTA
inhibited the carbonyl formation, the inhibition was not com-
plete. The bound copper seems to be in the Cu1 state, and
these Cu2-speci¢c chelators cannot e¡ectively remove the
bound copper.
Next, we examined whether the addition of dopamine and
L-ascorbate a¡ects the binding of copper to PrP23ÿ98 because
Table 1
Relative amino acid composition of control and oxidized copper-
loaded PrP23ÿ98
Amino acid Oxidized/control (molar ratio)
Copper content (mol Cu/mol protein)
0.03 0.59 1.46 2.11
Arginine 0.89 0.95 0.93 0.95
Aspartate 0.98 1.00 1.01 1.02
Glutamate 1.03 1.00 1.00 1.00
Glycine 1.00 1.00 1.00 1.00
Histidine 0.98 0.83 0.69 0.63
Lysine 0.92 0.97 0.92 0.89
Proline 1.01 0.93 0.97 0.99
Serine 1.09 1.00 0.96 0.96
Threonine 0.96 1.00 0.95 0.96
Tyrosine 0.96 0.98 1.01 0.99
PrP23ÿ98 and copper-loaded PrP23ÿ98 (2 WM) were incubated with
dopamine (100 WM) at 37‡C for 30 min, and after acid hydrolysis
of the proteins, the resulting samples were subjected to amino acid
analysis. Each protein preparation incubated without dopamine and
carried out through the same procedure was taken as control, and
ratios of the amount of each amino acid of oxidized protein to that
of control were calculated for the respective preparations by nor-
malization with the amount of glycine. This normalization should
be reasonable because this amino acid is not readily oxidized [12,25]
and contained most abundantly (40%) in the protein.
Fig. 2. Inhibitory e¡ect of metal chelators on carbonyl formation
on copper-loaded PrP23ÿ98. Copper-loaded PrP23ÿ98 (containing 1.04
mol of copper/mol of protein, 2 WM) and metal chelator (100 WM)
were incubated for 30 min at 37‡C, with 100 WM dopamine
(hatched bars) or 100 WM L-ascorbate (closed bars). Carbonyl con-
tents were determined as speci¢ed in Fig. 1. Signals of speci¢c
bands were quanti¢ed by densitometry and plotted as a percentage
of the control value (copper-loaded PrP23ÿ98 incubated without re-
ducing substances). Data were means þ S.D. (n = 3).
Table 2
Release of copper from copper-loaded PrP23ÿ98 by dopamine and L-
ascorbate
Copper content (mol Cu/
mol protein)
Copper releaseda (WM)
Dopamine L-Ascorbate
0.02 ND ND
0.44 0.123 þ 0.037 0.016 þ 0.017
0.89 0.336 þ 0.029 0.018 þ 0.012
1.04 0.538 þ 0.051 0.016 þ 0.005
2.10 0.826 þ 0.063 0.012 þ 0.023
2.52 1.147 þ 0.079 0.028 þ 0.023
aPrP23ÿ98 or copper-loaded PrP23ÿ98 was mixed at 2 WM with dopa-
mine or L-ascorbate, mixtures were immediately centrifuged in an
ultra¢ltration cup, and copper concentrations were measured as de-
tailed under Section 2. The measured concentrations were corrected
for the copper concentration of the bu¡er used. Values are
means þ S.D. of three independent experiments. ND, not detected.
Fig. 3. Redox cycling of the copper bound to PrP23ÿ98 in the pres-
ence of dopamine and L-ascorbate. Mixtures (1 ml) containing 50
mM Mes bu¡er (pH 7.5), copper-loaded PrP23ÿ98 (open circles), and
100 WM L-ascorbate (A) or 100 WM dopamine (B) were incubated at
37‡C, and oxidations of dopamine and L-ascorbate were traced spec-
trophotometrically at 490 nm and 265 nm, respectively. The same
measurements were carried out with the same mixture containing
copper^glycine (solid circles) in place of copper-loaded PrP23ÿ98. Ini-
tial rates of their oxidations catalyzed solely by protein-bound cop-
per (open triangles) were obtained by subtraction of the initial rates
of the reactions to be catalyzed by free copper (copper released in
the experiment of Table 2) from those experimentally observed with
copper-loaded PrP23ÿ98.
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these compounds are known to interact with copper. Dopa-
mine or L-ascorbate (100 WM, the ¢nal concentration) was
added to solutions of varying copper-loaded PrP23ÿ98, and
the amount of copper ¢lterable by ultra¢ltration was mea-
sured immediately after mixing. In the experiment with dopa-
mine, large amounts (14^26%) of ¢lterable copper were de-
tected (Table 2), indicating that the bound copper was
released to some degree and formed a complex with dopa-
mine. On the other hand, in the experiment with L-ascorbate,
the amount of copper released was marginal (less than 1.8%)
(Table 2).
To see how readily the PrP23ÿ98-bound copper redox cycles,
we did a kinetic study on oxidations of dopamine and L-as-
corbate in their incubation with copper-loaded PrP23ÿ98. The
initial rate of oxidation of dopamine observed as dopachrome
formation increased dependently on the copper concentration
(Fig. 3A). Since substantial amounts of the bound copper are
released by the interaction with dopamine (Fig. 3A), the rate
of reaction to be catalyzed by the released copper was sub-
tracted from the observed rate to estimate the initial rate of
reaction catalyzed solely by the PrP23ÿ98-bound copper. The
catalysis by the protein-bound copper was approximately
three times faster than that by free copper (Fig. 3A). In con-
trast, the oxidation of L-ascorbate was found to be markedly
suppressed compared to the reaction catalyzed by free copper.
Amounts of released copper were very low (6 0.02 WM) (Ta-
ble 2), but the catalysis by free copper is very powerful. The
protein-bound copper was redox inactive below a copper con-
centration of 2 WM; L-ascorbate oxidation by the protein-
bound copper started to increase above 2 WM.
4. Discussion
In the present study, we observed the carbonyl formation
on copper-loaded PrP23ÿ98 by its incubation with dopamine
and L-ascorbate. It was noted that the PrP23ÿ98-bound copper
was less catalytically active than free copper when L-ascorbate
was used as a reductant. Conversely, the protein-bound cop-
per catalyzed the oxidation of dopamine approximately three
times as rapid as free copper. Thus the copper-bound PrP23ÿ98
appears to act as dopamine oxidase, and this dopamine oxi-
dation process is coupled to carbonyl formation on the pro-
tein. The mechanism of the dopamine-induced carbonyl for-
mation may be delineated as follows. The copper catalysis of
the oxidation of catechol to o-quinone is mediated through
the formation of a Cu2^catechol complex, which favors the
transfer of electrons from catechol to Cu2 and the formation
of CuO2 from the resulting Cu
1 and O2 [21,22]. This CuO2
species e¡ectively oxidizes catechol or is cleaved to O32 and
Cu2. Generation of O32 always leads to formation of H2O2,
which is reduced by Cu1 to form OH radical. This highly
reactive radical directly attacks the protein backbone and side
chains of amino acid residues. Dopamine exists vastly in the
brain with fairly high concentrations in certain regions as
mentioned in Section 1, and high concentrations of copper
(100^250 WM) are released into the synaptic cleft [23]. Also,
it is reported that PrP is located on the synaptic membrane
[24]. Therefore, combination of these three components is fea-
sible at the synapse of neurons and possibly causes oxidative
damage to PrP, which might be associated with the pathology
of prion disease. In relation to pathogenesis of other neuro-
degenerative diseases, the pro-oxidant e¡ect of dopamine in
combination with copper was previously reported for oxida-
tive DNA damage [13].
The protein aggregation is observed in several brain neuro-
degenerative disorders, such as prion disease and Alzheimer’s
disease [3]. Recently, Requena et al. [12] have indicated that
copper-catalyzed oxidation induces extensive aggregation and
precipitation of the Syrian hamster recombinant SHa(29^231)
PrP. They hypothesized that the ensuing damage might cause
structural alterations that could be relevant to the conversion
of the soluble cellular isoform to the pathogenic and infec-
tious scrapie isoform. In our study, copper-loaded PrP23ÿ98
migrated mainly as a single band with a molecular mass of
monomer (8.2 kDa) upon non-reducing SDS^polyacrylamide
gel electrophoresis. The discrepancy between the result of
Rquena et al. [12] and ours may be interpreted as indicating
that the aggregation requires the C-terminal globular portion
of the protein.
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